Product Code: ETC6192470 | Publication Date: Sep 2024 | Updated Date: May 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Australias market for auto-disable syringes and IV cannulas is bolstered by healthcare policies promoting infection control and safe injection practices. Auto-disable syringes are crucial for immunization programs, while IV cannulas are widely used in hospital inpatient care. Stringent standards and increased healthcare expenditure contribute to the growing adoption of these products.
Auto-disable syringes are gaining ground in Australia due to their role in preventing reuse and ensuring safe injections. IV cannulas with safety features are becoming standard in hospitals. Government procurement preferences and WHO-recommended safety standards are accelerating their adoption.
The auto-disable syringe and IV cannula segment faces challenges related to high production costs and the need for strict compliance with WHO safety standards. Limited domestic manufacturing and reliance on imports increase vulnerability to international supply chain disruptions. Educating healthcare workers about proper use also remains a challenge.
Australias continued focus on safe injection practices and infection control presents a solid investment case in auto-disable syringes and IV cannulas. Opportunities abound in R&D for user-friendly, single-use devices and automation of manufacturing processes. Health policy support for safety-engineered devices can also attract public-private partnerships and grant funding for innovation-driven enterprises.
Government policies aimed at preventing the reuse of medical syringes and reducing healthcare-associated infections promote the use of auto-disable syringes and IV cannulas. TGA ensures rigorous assessment of these products, and public health policies include government-funded immunization programs that utilize auto-disable syringes. Infection control guidelines across healthcare settings also mandate the use of such devices, further driving the market.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Syringes Auto Disable Syringe and IV Cannulas Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Syringes Auto Disable Syringe and IV Cannulas Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Syringes Auto Disable Syringe and IV Cannulas Market - Industry Life Cycle |
3.4 Australia Syringes Auto Disable Syringe and IV Cannulas Market - Porter's Five Forces |
3.5 Australia Syringes Auto Disable Syringe and IV Cannulas Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Australia Syringes Auto Disable Syringe and IV Cannulas Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Australia Syringes Auto Disable Syringe and IV Cannulas Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Australia Syringes Auto Disable Syringe and IV Cannulas Market Trends |
6 Australia Syringes Auto Disable Syringe and IV Cannulas Market, By Types |
6.1 Australia Syringes Auto Disable Syringe and IV Cannulas Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Syringes Auto Disable Syringe and IV Cannulas Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Australia Syringes Auto Disable Syringe and IV Cannulas Market Revenues & Volume, By 0.05-1ML, 2021- 2031F |
6.1.4 Australia Syringes Auto Disable Syringe and IV Cannulas Market Revenues & Volume, By 2ML, 2021- 2031F |
6.1.5 Australia Syringes Auto Disable Syringe and IV Cannulas Market Revenues & Volume, By 3ML, 2021- 2031F |
6.1.6 Australia Syringes Auto Disable Syringe and IV Cannulas Market Revenues & Volume, By 5ML, 2021- 2031F |
6.1.7 Australia Syringes Auto Disable Syringe and IV Cannulas Market Revenues & Volume, By 10ML, 2021- 2031F |
6.1.8 Australia Syringes Auto Disable Syringe and IV Cannulas Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Australia Syringes Auto Disable Syringe and IV Cannulas Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Australia Syringes Auto Disable Syringe and IV Cannulas Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.2.3 Australia Syringes Auto Disable Syringe and IV Cannulas Market Revenues & Volume, By Clinics, 2021- 2031F |
6.2.4 Australia Syringes Auto Disable Syringe and IV Cannulas Market Revenues & Volume, By Others, 2021- 2031F |
7 Australia Syringes Auto Disable Syringe and IV Cannulas Market Import-Export Trade Statistics |
7.1 Australia Syringes Auto Disable Syringe and IV Cannulas Market Export to Major Countries |
7.2 Australia Syringes Auto Disable Syringe and IV Cannulas Market Imports from Major Countries |
8 Australia Syringes Auto Disable Syringe and IV Cannulas Market Key Performance Indicators |
9 Australia Syringes Auto Disable Syringe and IV Cannulas Market - Opportunity Assessment |
9.1 Australia Syringes Auto Disable Syringe and IV Cannulas Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Australia Syringes Auto Disable Syringe and IV Cannulas Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Australia Syringes Auto Disable Syringe and IV Cannulas Market - Competitive Landscape |
10.1 Australia Syringes Auto Disable Syringe and IV Cannulas Market Revenue Share, By Companies, 2024 |
10.2 Australia Syringes Auto Disable Syringe and IV Cannulas Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |